GlassScriptPhysician profile
Marlena Langford
NPI 1194168930
$2,362.29
in general payments reported to CMS, 2019-2025
25 companies · $400 in 2025
The $400 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $501 · 2022: $582 · 2023: $468 · 2024: $411 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,279.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $630.75 | 2021-2025 | |
| Abbott Laboratories | $583.36 | 2021-2025 | Proclaim, Eterna |
| Pfizer INC. | $146.58 | 2021-2024 | |
| Vertex Pharmaceuticals Incorporated | $134.73 | 2025 | |
| Amgen INC. | $108.43 | 2021-2023 | Prolia, Evenity |
| Biohaven Pharmaceutical Holding Company LTD. | $106.20 | 2022 | |
| Allergan, INC. | $98.81 | 2021-2022 | |
| Teleflex LLC | $93.00 | 2024 | Titan Sgs |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $56.88 | 2021-2025 | Relistor |
| Scilex Pharmaceuticals INC. | $50.33 | 2022-2024 | Ztlido |
| Biodelivery Sciences International, INC. | $46.69 | 2021 | |
| Horizon Therapeutics Plc | $41.76 | 2021 | |
| Lilly USA, LLC | $40.58 | 2021 | |
| Almatica Pharma LLC | $28.62 | 2022 | |
| Boston Scientific Corporation | $26.87 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $26.63 | 2021 | |
| Grt US Holding, INC. | $19.96 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $19.96 | 2025 | Dysport |
| Tersera Therapeutics LLC | $17.69 | 2024 | Prialt |
| Masimo Corporation | $15.36 | 2024 | Set and Rainbow Set |
| Spinal Simplicity, LLC | $15.30 | 2021 | |
| Amneal Pharmaceuticals LLC | $14.22 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $13.81 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.01 | 2023 | Seglentis |
| Arbor Pharmaceuticals, INC. | $12.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marlena Langford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.